A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib
Administered By
Awarded By
Contributors
- Riedel, Richard Francis Principal Investigator
Start/End
- March 27, 2019 - March 31, 2024